Back to search

Netherlands· NL-51e706760903

Mozobil 20 mg/ml, oplossing voor injectie

A plerixafor product containing plerixafor, registered in Netherlands by Genzyme Europe BV. The same ATC class is registered in 17 of our 19 countries.

ATC L03AX16

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedMozobil 20 mg/ml, oplossing voor inje…ATCL03AX16REGISTER NO.NL-51e706760903PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Plerixafor is registered in 17 of 19 countries.

Countries holding a registration under ATC L03AX16 (plerixafor), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 9 of them publish a price we can compare per daily dose

Plerixafor · ATC L03AX16

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
PLERIXAFOR
Manufacturer
Genzyme Europe BV
Country
Netherlands (NL)
ATC code
L03AX16
ATC class
Plerixafor
Defined daily dose
16.8 mg, P
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/09/537

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Plerixafor in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All plerixafor products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

  • Austria · Plerixafor Stada, Plerixafor Teva
  • Bulgaria · Plerixafor Msn
  • Czechia · Pleforbil, Plerixafor Msn
  • Germany · Plerixafor Amarox, Plerixafor Puren
  • Denmark · Plerixafor Seacross, Plerixafor Teva
  • Estonia · Plerixafor Auxilia
  • Spain · Plerixafor Eugia, Plerixafor Glenmark
  • Finland · Plerixafor Seacross, Plerixafor Viatris
  • France · Plerixafor Arrow, Plérixafor Eg
  • United Kingdom (Northern Ireland) · Plerixafor Amarox Limited, Plerixafor Eugia (Uk)
  • Croatia · Pleriksafor Msn, Pleriksafor Onkogen
  • Hungary · Plerixafor Msn, Plerixafor Onkogen
  • Ireland · Plerixafor Msn Labs Europe, Plerixafor Seacross
  • Iceland · Mozobil, Plerixafor Accord
  • Italy · Plerixafor Aurobindo, Plerixafor Eg
  • Liechtenstein · Mozobil, Plerixafor Accord
  • Lithuania · Plerixafor Auxilia
  • Norway · Mozobil, Plerixafor Accord
  • Poland · Plerixafor Biofar, Plerixafor Msn
  • Portugal · Plerixafor Eugia, Plerixafor Mylan
  • Romania · Plerixafor Msn Labs Europe
  • Sweden · Plerixafor Seacross, Plerixafor Teva
  • Slovenia · Pleriksafor Onkogen, Pleriksafor Teva
  • Slovakia · Plerixafor Msn, Plerixafor Onkogen

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dffe6158-36a1-49e9-baa4-b099054dbfb7
GET /v1/drugs/dffe6158-36a1-49e9-baa4-b099054dbfb7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": "Subcutaan gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/mozobil-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Plerixafor",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp102803",
  "excipients": [
    "NATRIUMCHLORIDE",
    "NATRIUMHYDROXIDE (E 524)",
    "STIKSTOF (HEAD SPACE) (E 941)",
    "WATER, GEZUIVERD",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "PLERIXAFOR"
  ],
  "leaflet_url": null,
  "authorised_at": "2009/07/31",
  "procedure_number": "EMEA/H/C/001030",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/09/537",
  "additional_monitoring": "N"
}

See everything about plerixafor.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.